Antiepileptogenesis after stroke—trials and tribulations: Methodological challenges and recruitment results of a Phase II study with eslicarbazepine acetate
Abstract There is currently no evidence to support the use of antiseizure medications to prevent unprovoked seizures following stroke. Experimental animal models suggested a potential antiepileptogenic effect for eslicarbazepine acetate (ESL), and a Phase II, multicenter, randomized, double‐blind, p...
Main Authors: | Matthias J. Koepp, Eugen Trinka, Yee‐Haur Mah, Carla Bentes, Susanne Knake, Gian Luigi Gigli, José M. Serratosa, Johan Zelano, Luís M. Magalhães, Ana Pereira, Joana Moreira, Patrício Soares‐da‐Silva |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-09-01
|
Series: | Epilepsia Open |
Subjects: | |
Online Access: | https://doi.org/10.1002/epi4.12735 |
Similar Items
-
Selected Molecular Targets for Antiepileptogenesis
by: Marek J. Pawlik, et al.
Published: (2021-09-01) -
Emerging Molecular Targets for Anti-Epileptogenic and Epilepsy Modifying Drugs
by: Katarzyna Łukasiuk, et al.
Published: (2023-02-01) -
Electroencephalogram in Children who Experienced First Unprovoked Seizure
by: Arinda Putri Auna Vanadia, et al.
Published: (2022-07-01) -
Risk of recurrence after a first unprovoked seizure in children
by: Catarina Maia, et al.
Published: (2017-05-01) -
ORGANIZATION OF HEALTH CARE TO PATIENTS WITH NEW-ONSET CONVULSIVE SEIZURE
by: G. I. Naumova
Published: (2009-06-01)